Auxilium Biotechnologies

bioprinted kidney and liver tissues in space for the first time, using its own orbital biomanufacturing device, and in February 2026 agreed to supply orbital 3D bioprinting capability aboard the Starlab commercial station.

国家
United States
US
覆盖范围
CNEUUS
cross-sector-intersections✓✓✓
监管机构fdafaa
技术
名称集群风险
太空器官生物打印cross-sector-intersections高→

由 BIOECON 依据一手资料编制。

合规 Bioecon 是信息中介,并非监管机构、认证机构或法律顾问。在与公共部门客户合作时 (依据 44-FZ / 223-FZ 的采购),Bioecon 仅作为独立分析平台,不收取供应商任何报酬。